Current Development Status and Consideration for Rare Hemorrhagic Disease Drugs

Autor: TANG Ling, ZOU Limin, DU Yu, QI Yueli, XIANG Meiyi, YANG Zhimin

Publikováno v: 罕见病研究, Vol 1, Iss 4, Pp 461-467 (2022)

Hemophilia is the only rare hereditary hemorrhagic disorder included in the First Rare Diseases catalogue. However, rare bleeding diseases identified in the clinic are far more common than hemophilia. Most other rare hemorrhagic disorders have less e

Externí odkaz: https://doaj.org/article/539000e7191240d294c876e406d34337

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The relationship between pneumonitis and programmed cell death-1/programmed cell death ligand 1 inhibitors among cancer patients

Autor: Xu, Dongmei, Liu, Hongmei, Xiang, Meiyi, Feng, Alei, Tian, Mei, Li, Donghua, Mao, Yantao, Zhang, Li, Zhang, Shuisheng, Tian, Yuan

Publikováno v: Medicine

Background: We put the meta-analysis into practice to reveal the relationship between the incidence risk of immune-related pneumonitis and the use of programmed cell death-1 (PD-1) and ligand 1 (PD-L1) inhibitors related pneumonitis in cancer patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b61029f8175d81f43df3017255cb875f
http://europepmc.org/articles/PMC7544380

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Advances in the Research of the Regulation of Chinese Traditional Medicine Monomer and Its Derivatives on Autophagy in Non-small Cell Lung Cancer].

Autor: Xiang M; Department of Cancer Biotherapy Center, the Third Affiliated Hospital of Kunming Medical University, Kunming 650500, China., Li R; Department of Cancer Biotherapy Center, the Third Affiliated Hospital of Kunming Medical University, Kunming 650500, China., Zhang Z; Department of Cancer Biotherapy Center, the Third Affiliated Hospital of Kunming Medical University, Kunming 650500, China., Song X; Department of Cancer Biotherapy Center, the Third Affiliated Hospital of Kunming Medical University, Kunming 650500, China.

Publikováno v: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2017 Mar 20; Vol. 20 (3), pp. 205-212.